| 000 | 03657nam a22003495i 4500 | ||
|---|---|---|---|
| 999 |
_c81697 _d81697 _x1 |
||
| 001 | 81697 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230221040151.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 141027s2015 ne | s |||| 0|eng d | ||
| 020 | _a9789401794664 | ||
| 024 | 7 |
_a10.1007/978-94-017-9466-4 _2doi |
|
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQK495.L25 _b2015 EB |
|
| 245 | 0 | 0 |
_aDan Shen (Salvia miltiorrhiza) in Medicine _nVolume 3, _pClinical Research _cedited by Xijun Yan. |
| 264 | 1 |
_aDordrecht, Netherlands _bSpringer _c2015 |
|
| 300 |
_a1 recurso en línea (XL, 296 p.) _b46 ilustraciones, 6 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aApplication in Medicine Systems -- Application in Surgical Systems -- Application in Orthopaedics and Traumatology -- Application in Pediatrics -- Application in Gynecology -- Application in Ophthalmology and Otorhinolaryngology -- Application in Other Diseases -- Precautions, Side-Effects and Adverse Reactions -- Overview of Dantonicâ{u282D}- Therapeutic Effects of Dantonicâ{u282F}n Coronary Heart Disease -- The Therapeutic Effect of Dantonicâ{u282F}n High Risk Factors of Coronary Heart Disease -- The Effect of Dantonicâ{u282F}n Diabetes and its Serious -- Effect of Dantonicâ{u282F}n Prevention of High Altitude Myocardial Hypoxidosis -- The Mechanism of Dantonicâ{u2829}n Treating Coronary Heart Disease -- Toxicity and Side-Effects of Dantonicâ{u282D}- Effect of Dantonicâ{u282F}n the treatment of Other Diseases -- Ancient and Modern Literature Research on Danshen Prescriptions. | |
| 520 | _aThis book reviews research on Dan Shen, compiles data from clinical trials and biological experiments, and summarizes the latest research advances. It covers the medicinal herb, herbal pieces, and new proprietary drugs that contain it; it also covers simple and compound, traditional and contemporary formulas, and addresses a broad range of subjects, including: standardized cultivation; biodiversity; effective substances and their biological activities; quality control; and clinical trials. The book goes on to present the clinical trials on Dantonic, especially focusing on its therapeutic effects for coronary heart disease. It discusses compound prescriptions and compatibilities, from the herbal piece level to composition level, and describes approaches to research on modern Chinese medicine. Â{u05AF}lume 1 describes the biology and chemistry of Dan Shen, while Volume 2 focuses on pharmacology and quality control. Volume 3 describes the clinical research on Dan Shen. ÂŤitor Xijun Yan is the President of Tianjin Tasly Group and a Member of the TCM Standardization Technical Committee. Gathering contributions from more than 100 authors working in the field of pharmaceutical and clinical research, the book presents and analyzes the available information from multiple aspects, reflects the current status of Dan Shen research, and offers an essential reference work for further research and development. | ||
| 988 | _aEBOOK, EBSPRINGER | ||
| 650 | 7 |
_aFarmacología _2embne _9137893 |
|
| 650 | 7 |
_aSalvias _9671889 _2embne |
|
| 700 | 1 |
_aYan, Xijun _eeditor literario _994275 _0Local |
|
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-9466-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b11/2020 _dz _eIG _feng _gne _h0 |
||